Record NNP B-NP O
date NN I-NP O
: : O O
2094-05-20 CD O B-DATE
CARDIOLOGY NN B-NP O
OXFORD NNP B-NP B-HOSPITAL
DELTA NNP I-NP I-HOSPITAL
CLINIC NN I-NP I-HOSPITAL
* JJ B-NP O
{font-family NN I-NP O
: : O O
Verdana NNP B-NP O
, , O O
Helvetica NNP B-NP O
, , O O
sans-serif,Arial JJ B-NP O
;font-size NN I-NP O
: : O O
9pt JJ B-NP O
; : O O
} : O O
table NN B-NP O
{border NN I-NP O
:0px NN I-NP O
} . O O
.dataitem NN B-NP O
content NN I-NP O
FixWidth NNP I-NP O
, , I-NP O
.labchooserText JJ I-NP O
{font-family NN I-NP O
: : O O
' POS B-NP O
Courier NNP I-NP O
New' NNP I-NP O
, , O O
' '' O O
Courier NNP B-NP O
'; , O O
width JJ B-NP O
:760px NN I-NP O
; : O O
white-space NN B-NP O
: : O O
pre NN B-NP O
; : O O
margin-top:-10px JJ B-NP O
;margin-bottom:-18px JJ I-NP O
; : O O
border NN B-NP O
:1px IN B-PP O
solid JJ B-NP O
black JJ I-NP O
; : O O
} : O O
.visitnote NN B-NP O
text NN I-NP O
, , O O
.visitnote NNP B-NP O
concept NN I-NP O
, , O O
.visitnote NN B-NP O
section NN I-NP O
, , O O
.tx NN B-NP O
summary NN I-NP O
text NN I-NP O
{ VBZ B-VP O
} RB O O
ul JJ B-NP O
{margin NN I-NP O
:1em IN B-SBAR O
0em PRP B-NP O
2em VBP B-VP O
0em PRP B-NP O
; : O O
} : O O
.dataitem JJ B-NP O
title NN I-NP O
, , O O
.tx NN B-NP O
summary NN I-NP O
title NN I-NP O
{ JJ I-NP O
font-weight JJ I-NP O
:bold NN I-NP O
; : O O
} : O O
li JJ B-NP O
{display NN I-NP O
: : O O
inline NN B-NP O
;margin NN I-NP O
:0 IN B-PP O
0 CD B-NP O
0 CD I-NP O
0em NN I-NP O
; : O O
} : O O
.ulName NN B-NP O
{font-weight JJ I-NP O
: : O O
bold JJ B-NP O
; : O O
display NN B-NP O
: : O O
block NN B-NP O
;margin NN I-NP O
:0 IN B-PP O
0 CD B-NP O
0 CD I-NP O
0em NN I-NP O
; : O O
} : O O
.liName NN B-NP O
{font-family NN I-NP O
: : O O
" `` O O
Verdana NNP B-NP O
" '' B-NP O
;font-weight JJ I-NP O
: : O O
bold JJ B-ADJP O
; : O O
} : O O
.liText JJ B-NP O
{text-align NN I-NP O
: : O O
left VBN B-VP O
; : O O
} CC O O
.tx NN B-NP O
summary NN I-NP O
tabulate NN I-NP O
name NN I-NP O
{vertical-align NN I-NP O
: : O O
top;text-align JJ B-NP O
: : O O
left JJ B-NP O
;white-space NN I-NP O
: : O O
nowrap; RB B-ADVP O
} VBG B-LST O
.tx NN B-NP O
summary NN I-NP O
tabulate NN I-NP O
text NN I-NP O
{vertical-align JJ I-NP O
: : O O
top;white-space NN B-NP O
: : O O
nowrap; RB B-ADVP O
} VBG B-LST O
.labCode NNP B-NP O
{text-align JJ I-NP O
: : O O
center NN B-VP O
;text-decoration NN B-NP O
: : O O
underline NN B-NP O
; : O O
} : O O
.labValueSummary JJ B-NP O
{text-align JJ I-NP O
: : I-NP O
center NN I-NP O
; : O O
} : O O
table NN B-NP O
.labTable JJ I-NP O
{border NN I-NP O
: : O O
1px CD B-NP O
# # I-NP O
4D3F46 CD I-NP O
solid JJ I-NP O
;text-align JJ I-NP O
: : O O
center NN B-VP O
;vertical-align NN B-NP O
: : O O
top;padding-left NN B-NP O
: : O O
5px;padding-right JJ B-NP O
: : O O
5px CD B-NP O
; : O O
} CC O O
table NN B-NP O
.labTable JJ I-NP O
td NN I-NP O
{vertical-align NN I-NP O
: : O O
top;padding-left NN B-NP O
: : O O
1px;padding-right JJ B-NP O
: : B-VP O
1px;padding-top JJ B-ADJP O
: : O O
0px;padding-bottom JJ B-ADJP O
: : O O
0px CD B-NP O
; : O O
} CC O O
table NN B-NP O
.infoTable JJ I-NP O
{border NN I-NP O
: : O O
0px CD B-NP O
# # I-NP O
4D3F46 CD I-NP O
solid JJ I-NP O
;padding-right NN I-NP O
: : O O
5px;border-top JJ B-NP O
: : O O
0px CD B-NP O
solid JJ I-NP O
# # I-NP O
4D3F46;margin-top JJ I-NP O
: : O O
0px CD B-NP O
;margin NN I-NP O
: : O O
3 CD B-NP O
3 CD I-NP O
3 CD I-NP O
3px NN I-NP O
; : O O
} : O O
Narrative JJ B-NP O
Note NN I-NP O
: : O O
Chief NNP B-NP O
Complaint NN I-NP O
Cardiology NNP B-NP O
Admission NNP I-NP O
Note NN I-NP O
Christopher NNP B-NP B-PATIENT
Powell NNP I-NP I-PATIENT
# # B-NP O
070 CD I-NP B-MEDICALRECORD
27 CD I-NP I-MEDICALRECORD
68 CD O I-MEDICALRECORD
5/20/94 CD B-NP B-DATE
at IN B-PP O
11:30 CD B-NP O
am VBP O O
Mr NNP B-NP O
Powell NNP I-NP B-PATIENT
is VBZ B-VP O
admitted VBN I-VP O
to TO B-PP O
Cardiology NNP B-NP O
clinic NN I-NP O
s/p NN I-NP O
cath NN I-NP O
and CC I-NP O
PTCA/stent NN I-NP O
( -LRB- I-NP O
2.25 CD I-NP O
x NN I-NP O
12 CD B-NP O
Taxus NN I-NP O
) -RRB- I-NP O
to TO B-PP O
the DT B-NP O
LAD NN I-NP O
History NN B-NP O
of IN B-PP O
Present NNP B-NP O
Illness NNP I-NP O
This DT B-NP O
69 CD I-NP B-AGE
yo NNP I-NP O
gentleman NN I-NP O
has VBZ B-VP O
a DT B-NP O
hx NN I-NP O
of IN B-PP O
CAD NNP B-NP O
dating VBG B-VP O
back RB B-NP O
several JJ I-NP O
years NNS I-NP O
. . O O
He PRP B-NP O
underwent VBD B-VP O
CABG NNP B-NP O
x NN I-NP O
3 CD I-NP O
in IN B-PP O
2092 CD B-NP B-DATE
at IN B-PP O
WMMC NNP B-NP B-HOSPITAL
after IN B-PP O
being VBG B-VP O
diagnosed VBN I-VP O
with IN B-PP O
CAD NNP B-NP O
after IN B-PP O
presenting VBG B-VP O
with IN B-PP O
symptoms NNS B-NP O
of IN B-PP O
jaw NN B-NP O
pain NN I-NP O
and CC O O
SOB. NNP B-NP O
Immediately RB B-ADVP O
after IN B-PP O
surgery NN B-NP O
he PRP B-NP O
was VBD B-VP O
told VBN I-VP O
there EX B-NP O
was VBD B-VP O
likely JJ B-NP O
a DT I-NP O
problem NN I-NP O
with IN B-PP O
one NN B-NP O
of IN B-PP O
the DT B-NP O
grafts NNS I-NP O
. . O O
He PRP B-NP O
began VBD B-VP O
to TO I-VP O
have VB I-VP O
symptoms NNS B-NP O
of IN B-PP O
jaw NN B-NP O
pain NN I-NP O
and CC I-NP O
dypnea NN I-NP O
within IN B-PP O
a DT B-NP O
few JJ I-NP O
weeks NNS I-NP O
of IN B-PP O
surgery NN B-NP O
and CC O O
presented VBD B-VP O
to TO B-PP O
Beloit NNP B-NP B-HOSPITAL
State NNP I-NP I-HOSPITAL
where WRB B-ADVP O
he PRP B-NP O
had VBD B-VP O
cath NN B-NP O
within IN B-PP O
6 CD B-NP O
weeks NNS I-NP O
of IN B-PP O
CABG- NNP B-NP O
at IN B-PP O
that DT B-NP O
time NN I-NP O
his PRP$ B-NP O
LAD NN I-NP O
graft NN I-NP O
was VBD B-VP O
down RB B-ADVP O
and CC O O
his PRP$ B-NP O
distal JJ I-NP O
LAD NN I-NP O
was VBD B-VP O
stenosed VBN I-VP O
. . B-NP O
Failed NNP I-NP O
attempt NN I-NP O
to TO B-VP O
stent VB I-VP O
the DT B-NP O
distal JJ I-NP O
LAD NN I-NP O
, , O O
but CC O O
it PRP B-NP O
was VBD B-VP O
PTCA NNP B-NP O
'd NNP I-NP O
with IN B-PP O
no DT B-NP O
real JJ I-NP O
relief NN I-NP O
of IN B-PP O
his PRP$ B-NP O
symptoms NNS I-NP O
. . O O
Last NNP B-NP O
year NN I-NP O
, , O O
he PRP B-NP O
presented VBD B-VP O
here RB B-ADVP O
with IN B-PP O
further JJ B-NP O
progression NN I-NP O
of IN B-PP O
his PRP$ B-NP O
anginal JJ I-NP O
equivalent JJ I-NP O
and CC I-NP O
underwent JJ I-NP O
cath NN I-NP O
which WDT B-NP O
showed VBD B-VP O
further JJ B-NP O
stenosis NN I-NP O
of IN B-PP O
the DT B-NP O
distal JJ I-NP O
LAD. NNP I-NP O
There EX B-NP O
was VBD B-VP O
no DT B-NP O
PCI NN I-NP O
option NN I-NP O
available JJ B-ADJP O
. . O O
He PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
aggressively RB I-VP O
managed VBN I-VP O
with IN B-PP O
medications NNS B-NP O
and CC O O
initially RB B-VP O
his PRP$ B-NP O
jaw NN I-NP O
pain NN I-NP O
improved VBN B-VP O
, , O O
but CC O O
the DT B-NP O
dyspnea NN I-NP O
has VBZ B-VP O
persisted VBN I-VP O
. . O O
Unfortunately RB O O
the DT B-NP O
jaw NN I-NP O
pain NN I-NP O
has VBZ B-VP O
reoccurred VBN I-VP O
and CC O O
he PRP B-NP O
has VBZ B-VP O
become VBN I-VP O
more RBR B-ADJP O
symptomatic JJ I-ADJP O
. . O O
He PRP B-NP O
now RB B-ADVP O
presented VBD B-VP O
for IN B-PP O
cath NN B-NP O
. . O O
Today NN B-NP O
he PRP B-NP O
arrived VBD B-VP O
via IN B-PP O
SDA NNP B-NP O
for IN B-PP O
cath NN B-NP O
that WDT B-NP O
showed VBD B-VP O
his PRP$ B-NP O
native JJ I-NP O
disease NN I-NP O
to TO B-VP O
be VB I-VP O
severe JJ B-ADJP O
with IN B-PP O
a DT B-NP O
70 CD I-NP O
% NN I-NP O
stenosis NN I-NP O
involving VBG B-VP O
the DT B-NP O
ostium NN I-NP O
of IN B-PP O
the DT B-NP O
first JJ I-NP O
diagonal JJ I-NP O
branch NN I-NP O
. . O O
The DT B-NP O
mid-distal JJ I-NP O
LAD NN I-NP O
is VBZ B-VP O
small JJ B-ADJP O
and CC O O
tapering NN B-NP O
with IN B-PP O
diffuse NN B-NP O
disease NN I-NP O
up IN B-NP O
to TO I-NP O
80 CD I-NP O
% NN I-NP O
. . O O
The DT B-NP O
first JJ I-NP O
diagonal JJ I-NP O
has VBZ B-VP O
a DT B-NP O
high JJ I-NP O
grade NN I-NP O
ostial JJ I-NP O
stenosis NN I-NP O
. . O O
LCX NNP B-NP O
has VBZ B-VP O
40-50 CD B-NP O
% NN I-NP O
stenosis NN I-NP O
proximal NN I-NP O
to TO B-PP O
the DT B-NP O
first JJ I-NP O
OM. NNP I-NP O
RCA NNP I-NP O
has VBZ B-VP O
80 CD B-NP O
% NN I-NP O
stenosis NN I-NP O
proximally RB B-ADVP O
with IN B-PP O
competitive JJ B-NP O
flow NN I-NP O
from IN B-PP O
the DT B-NP O
SVG. NNP I-NP O
The DT B-NP O
LIMA-&gt JJ I-NP O
; : O O
D1 NNP B-NP O
is VBZ B-VP O
patent NN B-NP O
and CC O O
the DT B-NP O
SVG-&gt JJ I-NP O
; : O O
RCA NNP B-NP O
is VBZ B-VP O
patent NN B-NP O
. . O O
The DT B-NP O
SVG-&gt NNP I-NP O
; : O O
LAD NNP B-NP O
is VBZ B-VP O
not RB I-VP O
visualized VBN I-VP O
. . O O
The DT B-NP O
mid-LAD NN I-NP O
lesion NN I-NP O
was VBD B-VP O
treated VBN I-VP O
with IN B-PP O
PTCA/stenting VBG B-VP O
with IN B-PP O
a DT B-NP O
2.25 CD I-NP O
x NN I-NP O
12 CD I-NP O
mm CD I-NP O
Taxus NNP I-NP O
stent NN I-NP O
. . O O
He PRP B-NP O
arrived VBD B-VP O
on IN B-PP O
floor NN B-NP O
5 CD I-NP O
pain NN I-NP O
free JJ I-NP O
and CC O O
in IN B-PP O
no DT B-NP O
distress NN I-NP O
. . O O
Past NNP B-NP O
Medical NNP I-NP O
History NNP I-NP O
CAD NN B-NP O
CABG NNP B-NP O
x NN I-NP O
3 CD B-NP O
2092 CD I-NP B-DATE
( -LRB- I-NP O
LIMA-&gt NNP I-NP O
; : O O
LAD NNP B-NP O
, , O O
SVG-&gt NNP B-NP O
; : O O
LAD NNP B-NP O
, , O O
SVG-&gt NNP B-NP O
; : O O
RCA NNP B-NP O
) -RRB- O O
Hyperlipidemia NNP B-NP O
Hypertension NN B-NP O
Diabetes NNS B-NP O
Anxiety/depression NN B-NP O
Allergies . O O
ACE-i-&gt NNP B-NP O
; : O O
cough NN B-NP O
Diovan-&gt JJ B-NP O
; : O O
fatigue NN B-NP O
Zocor NNP B-NP O
, , O O
crestor-&gt JJ B-NP O
; : O O
myalgias NNS B-NP O
Metformin-&gt NNP B-NP O
; : O O
GI NNP B-NP O
intolerance IN B-LST O
Social NNP B-NP O
History NNP I-NP O
Married VBN B-ADJP O
, , O O
4 CD B-NP O
children NNS I-NP O
Lives NNS B-NP O
with IN B-PP O
wife NN B-NP O
Retired VBN B-NP O
floor NN I-NP B-PROFESSION
covering VBG I-NP I-PROFESSION
installer NN I-NP I-PROFESSION
, , O O
works VBZ B-VP O
for IN B-PP O
son NN B-NP O
doing VBG B-VP O
accounting NN B-NP B-PROFESSION
Habits PRP$ O O
ETOH NNP B-NP O
: : O O
3 CD B-NP O
drinks/week NN I-NP O
on IN B-PP O
average NN B-NP O
Smoking VBG B-VP O
: : O O
quit VB B-VP O
30 CD B-NP O
yrs NNS I-NP O
ago IN O O
Caffeine NNP B-NP O
: : O O
5-6/day NN B-NP O
( -LRB- I-NP O
coffee NN I-NP O
and CC I-NP O
diet NN I-NP O
coke NN I-NP O
) -RRB- O O
Diet NNP B-NP O
: : O O
diabetic NN B-NP O
Exercise NN B-NP O
: : O O
unable JJ O O
to TO B-VP O
do VB I-VP O
much JJ B-NP O
d/t NN I-NP O
symptoms NNS I-NP O
Family NNP B-NP O
History NN I-NP O
7 CD B-NP O
sbilings NNS I-NP O
with IN B-PP O
HTN NNP B-NP O
Father NN B-NP O
with IN B-PP O
heart NN B-NP O
problems NNS I-NP O
- : O O
died VBD B-VP O
at IN B-PP O
86 CD B-NP B-AGE
Medications NNS B-NP O
At IN B-PP O
Home NNP B-NP O
: : O O
Imdur NNP B-NP O
60 CD I-NP O
mg NN I-NP O
QD . O O
Ranexa NNP B-NP O
1000 CD I-NP O
mg NN I-NP O
BID . O O
Lasix NNP B-NP O
20 CD I-NP O
mg NN I-NP O
QD . O O
Lipitor NNP B-NP O
40 CD I-NP O
mg NN I-NP O
QD . O O
Plavix NNP B-NP O
75 CD I-NP O
mg NN I-NP O
QD . O O
Lexapro NNP B-NP O
10 CD I-NP O
mg NN I-NP O
QD . O O
Lopressor NNP B-NP O
12.5 CD I-NP O
mg NN I-NP O
BID . O O
Protonix NNP B-NP O
40 CD I-NP O
mg NN I-NP O
QD . O O
KCL NN B-NP O
10 CD B-NP O
mEq NNS I-NP O
QD . O O
ECASA NNP B-NP O
325 CD I-NP O
mg NN I-NP O
QD NN I-NP O
Norvasc NNP B-NP O
10 CD I-NP O
mg NN I-NP O
QD . O O
Ambien JJ B-NP O
10 CD I-NP O
mg NN I-NP O
QD . O O
Physical NNP B-NP O
Exam NNP I-NP O
Height NN B-NP O
: : O O
67 CD B-NP O
" '' O O
Weight NNP B-NP O
: : O O
180 CD B-NP O
lbs NNS I-NP O
VS NNP B-NP O
: : O O
100/50 CD B-NP O
, , I-NP O
63 CD I-NP O
, , I-NP O
18 CD O O
Monitor NNP B-NP O
: : O O
SR/SB NN B-NP O
Gen NNP B-NP O
: : O O
well RB B-ADVP O
appearing VBG B-VP O
caucasian JJ B-NP O
male NN I-NP O
in IN B-PP O
NAD NNP B-NP O
Neuro NNP B-NP O
: : O O
alert JJ B-ADJP O
, , O O
oriented VBN B-NP O
x NN I-NP O
3 CD I-NP O
, , I-NP O
speech NN I-NP O
clear JJ I-NP O
and CC I-NP O
articulate JJ I-NP O
. . O O
CN NNP B-NP O
II-XII NNP I-NP O
intact JJ I-NP O
. . O O
Strength NNP B-NP O
5/5 CD I-NP O
BUE- CC O O
lower JJR B-NP O
extremities NNS I-NP O
not RB B-VP O
tested VBN I-VP O
d/t NN B-NP O
activity NN I-NP O
limitations NNS I-NP O
. . O O
No DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
Neck NNP B-NP O
: : O O
supple NN B-NP O
, , O O
thyroid VBD B-VP O
midline NN B-NP O
without IN B-PP O
nodularity NN B-NP O
. . O O
JVP NNP B-NP O
flat JJ I-NP O
, , O O
no DT B-NP O
HJR. NNP I-NP O
Carotid NNP I-NP O
pulses NNS I-NP O
1+ VBD B-VP O
, , O O
no DT B-NP O
bruits NNS I-NP O
. . O O
No DT B-NP O
appreciable NN I-NP O
adenopathy NN I-NP O
Cardiac NNP B-NP O
: : O O
regular JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
S3/S4 NNP I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
. . O O
PMI NN B-VP O
not RB I-VP O
displaced VBN I-VP O
Resp NN B-NP O
: : O O
clear JJ B-NP O
anteriorly CC O O
Abd NNP B-NP O
: : O O
soft JJ B-NP O
, , I-NP O
non-tender/non-distended JJ I-NP O
. . O O
No DT B-NP O
HSM/masses/bruits NNPS I-NP O
. . B-NP O
Bowel NNP I-NP O
sounds VBZ B-VP O
in IN B-PP O
all DT B-NP O
quads NNS I-NP O
Ext JJ B-NP O
: : O O
left JJ B-NP O
femoral JJ I-NP O
sheath NN I-NP O
in IN B-PP O
place NN B-NP O
. . O O
No DT B-NP O
hematoma/ooze NN I-NP O
, , O O
? . B-NP O
soft JJ I-NP O
bruit NN I-NP O
. . O O
Pulses '' O O
1+ CD B-NP O
DP/PT NNP I-NP O
, , O O
no DT B-NP O
c/c/e NN I-NP O
. . O O
Review NNP B-NP O
of IN I-NP O
Systems NNPS O O
Negative JJ B-ADJP O
in IN B-PP O
detail NN B-NP O
except IN B-PP O
as IN I-PP O
noted VBN B-NP O
above IN O O
Lab NNP B-NP O
Test NNP I-NP O
Labs NNS B-NP O
: : O O
EKG NNP B-NP O
: : O O
Disposition NN B-NP O
and CC I-NP O
Plans NNS I-NP O
Impression NN B-NP O
: : O O
69 CD B-NP B-AGE
yo NNP I-NP O
with IN B-PP O
CAD NNP B-NP O
, , O O
s/p NN B-NP O
CABG NN I-NP O
with IN B-PP O
early JJ B-NP O
graft NN I-NP O
stenosis NN I-NP O
, , O O
now RB B-ADVP O
s/p JJ B-NP O
PTCA/stent NN I-NP O
to TO B-PP O
mid MD B-NP O
LAD NNP I-NP O
w/DES NNS B-LST O
Plan NNP B-NP O
: : O O
1 LS O O
. . B-NP O
Cardiac NNP I-NP O
: : O O
HR/BP RB B-VP O
well RB I-VP O
controlled VBN I-VP O
. . O O
Continue NNP B-NP O
current JJ I-NP O
meds NNS I-NP O
. . O O
Full NNP B-NP O
dose NN I-NP O
ASA NNP I-NP O
and CC O O
plavix VB B-VP O
indefinitely RB B-ADVP O
. . O O
Stop VB B-VP O
PPI NNP B-NP O
on IN B-PP O
plavix NN B-NP O
with IN B-PP O
new JJ B-NP O
DES. NNP I-NP O
Recently RB B-VP O
increase VB I-VP O
lipitor NN B-NP O
to TO B-PP O
40 CD B-NP O
mg NN I-NP O
QD- NNP I-NP O
will MD B-VP O
check VB I-VP O
fasting VBG I-VP O
lipids NNS B-NP O
in IN B-PP O
am VBP B-VP O
along RB B-ADVP O
with IN B-PP O
LFT NNP B-NP O
's POS B-NP O
. . I-NP O
Adjust NNP I-NP O
dose NN I-NP O
further RB B-ADVP O
as IN B-SBAR O
needed VBN B-VP O
. . O O
Remove VB B-VP O
sheath NN B-NP O
once RB B-ADVP O
PTT NNP B-NP O
normalizes VBZ B-VP O
. . B-NP O
Ambulate NNP I-NP O
once RB I-NP O
activity NN I-NP O
restrictions NNS I-NP O
lifted VBD B-VP O
. . O O
Continue NNP B-NP O
nitrates NNS I-NP O
for IN B-PP O
now RB B-NP O
given VBN I-NP O
intramyocardial JJ I-NP O
vessel NN I-NP O
and CC O O
severe JJ B-NP O
native JJ I-NP O
distal JJ I-NP O
LAD NN I-NP O
disease NN I-NP O
. . O O
Increase '' O O
activity NN B-NP O
post NN I-NP O
DC NNP I-NP O
as IN B-PP O
tolerated VBN B-NP O
. . O O
. . O O
2. DT B-NP O
Endo NNP I-NP O
: : O O
Diabetic NNP B-NP O
on IN B-PP O
glyburide- NNS B-NP O
continue VBP B-VP O
for IN B-ADVP O
now RB I-ADVP O
. . O O
Check VB B-VP O
FS NNS B-NP O
BID- CC O O
insulin NN B-NP O
scale NN I-NP O
as IN B-PP O
needed VBN B-NP O
. . O O
3. DT B-NP O
GI NNP I-NP O
: : O O
on IN B-PP O
protonix NN B-NP O
- : O O
will MD B-VP O
change VB I-VP O
to TO I-VP O
zantac VB I-VP O
while IN B-ADVP O
on IN B-PP O
plavix NN B-NP O
to TO B-VP O
prevent VB I-VP O
drug NN B-NP O
interaction NN I-NP O
with IN B-PP O
PPI NNP B-NP O
's/plavix , O O
. . B-NP O
Guaiac NNP I-NP O
all DT I-NP O
stools NNS I-NP O
4 LS O O
. . B-NP O
Psych NNP I-NP O
: : O O
anxiety/depression NN B-NP O
- : O O
continue VBP B-VP O
lexapro VBG I-VP O
Further JJ B-NP O
plans NNS I-NP O
per IN B-PP O
Dr NNP B-NP O
Paulson NNP I-NP B-DOCTOR
Tonya NNP B-NP B-DOCTOR
Adamson NNP I-NP I-DOCTOR
, , O O
MS NNP B-NP O
, , O O
NP-C . O O
B NNP B-NP O
36295 CD I-NP B-PHONE
Document NNP B-NP O
Status NNP I-NP O
: : O O
Preliminary JJ O O
